| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 99.11B | 95.26B | 99.36B | 88.04B | 92.41B | 85.13B |
| Gross Profit | 12.56B | 12.84B | 12.03B | 9.95B | 8.80B | 10.23B |
| EBITDA | 7.80B | 8.38B | 7.54B | 6.20B | 4.82B | 6.36B |
| Net Income | 4.19B | 4.67B | 3.89B | 2.74B | 1.13B | 3.30B |
Balance Sheet | ||||||
| Total Assets | 77.58B | 84.53B | 83.72B | 76.04B | 78.77B | 78.30B |
| Cash, Cash Equivalents and Short-Term Investments | 15.06B | 14.44B | 7.75B | 13.44B | 8.17B | 12.81B |
| Total Debt | 6.78B | 105.00M | 6.71B | 6.81B | 6.91B | 7.01B |
| Total Liabilities | 37.13B | 40.31B | 42.02B | 35.51B | 39.11B | 37.80B |
| Stockholders Equity | 40.45B | 44.22B | 41.69B | 40.53B | 39.66B | 40.50B |
Cash Flow | ||||||
| Free Cash Flow | 1.15B | 9.61B | -2.31B | 8.02B | -2.67B | 945.00M |
| Operating Cash Flow | 1.44B | 11.42B | -971.00M | 10.95B | 2.38B | 4.65B |
| Investing Cash Flow | -304.00M | -1.71B | -1.34B | -2.87B | -5.03B | -3.67B |
| Financing Cash Flow | -795.00M | -3.02B | -3.38B | -2.82B | -2.02B | -2.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥52.90B | 11.77 | ― | 4.90% | -4.13% | 19.71% | |
70 Outperform | ¥49.04B | 12.38 | ― | 3.78% | 24.67% | 72.89% | |
67 Neutral | ¥69.71B | 8.55 | ― | 2.56% | 2.50% | 21.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥43.94B | 10.01 | ― | 2.26% | 17.46% | 102.48% | |
60 Neutral | ¥60.23B | 13.89 | ― | 1.57% | 4.01% | 21.41% | |
57 Neutral | ¥47.12B | 11.94 | ― | 2.84% | 21.15% | 18.25% |